XYMOGEN, the Orlando-based health sciences company, has earned Australia’s prestigious certification from the Therapeutic Goods Administration (TGA), that country’s equivalent to the U.S. Federal Drug Administration.

TGA certification is internationally recognized for having one of the world’s most rigorous GMP audit processes in the dietary supplement industry, standards that are very similar to pharmaceutical-level GMP requirements. XYMOGEN’s team spent two years of intense work and dedication in order to earn the certification.

Specifically, according to TGA requirements, XYMOGEN had to demonstrate the strictest level of adherence to manufacturing and quality standards and practices. TGA requirements exceed those established by the FDA.

Learn more about XYMOGEN products at www.xymogen.com.